Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

The Kruskal: Wallis test indicated statistically significant differences (p < 0.001) for pantothenic acid, calcium, chlorine, iron, magnesium, manganese, potassium, vitamin A, vitamin C, vitamin D, and vitamin E across age classes.

Source: 3.3. Variability of Single Micronutrient Content Among Different Age Ranges. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

A Cross-Sectional Study on Protein Substitutes for Paediatric Phenylketonuria Diet: Time to Pay Attention

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

A Cross-Sectional Study on Protein Substitutes for Paediatric Phenylketonuria Diet: Time to Pay Attention

Cross-sectional study · Nutrients · 2025

Original publication title

A Cross-Sectional Study on Protein Substitutes for Paediatric Phenylketonuria Diet: Time to Pay Attention

Albina Tummolo; Rosa Carella; Donatella De Giovanni; Vito Di Tullio; Letizia Lorusso; Nicola Bartolomeo

© 2025 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Introduction: Protein substitutes (PSs) free of phenylalanine (Phe) represent the primary source of proteins and micronutrients in dietary management of classical Phenylketonuria (PKU). Over the last few years, the composition of PSs has undergone rapid and significant improvements, including the development of slow-release amino acid technologies, the introduction of glycomacropeptide-based products, as well as enhancements in taste and the variety of available formulations. However, their micronutrient content has received limited attention. This work aims to analyse the micronutrient composition of all PS formulations available in Italy for paediatric PKU patients and compare their micronutrient contribution to the recommended dietary allowance (RDA) and assess variability among products and age groups. Materials and Methods: The content of 28 micronutrients was analysed in 63 PSs, grouped according to the age ranges defined by the RDA guidelines: 0 to 6 months, 6 to 12 months, 1 to 3 years, 3 to 8 years, 8 to 14 years.

The micronutrient content was standardised for 10 g of protein equivalent (PE). Results: Compared to the RDA, many micronutrients were found to be over-supplemented across all age groups, particularly in the 0 to 6 month group, where peak levels were observed for vitamin K, chromium, and manganese. The 1 to 3 age group showed the lowest levels of supplementation, with most micronutrients falling within the sub-supplementation range. The variability in supplementation among PSs was broad and showed the highest values in the latter age ranges, reaching maximum levels for biotin and copper.

Among different ages, the variability was higher in the first two age ranges, particularly for vitamin A. Choline is not supplemented in many PSs across different age ranges. Conclusions: Many micronutrients supplemented in the PSs exceed the RDA for all age groups, with high variability among different PSs and age groups. When prescribing a PS, the daily amount of synthetic proteins of the diet should be considered in order to evaluate the real daily intake of micronutrients in a PKU diet.

Authors’ abstract

Introduction: Protein substitutes (PSs) free of phenylalanine (Phe) represent the primary source of proteins and micronutrients in dietary management of classical Phenylketonuria (PKU). Over the last few years, the composition of PSs has undergone rapid and significant improvements, including the development of slow-release amino acid technologies, the introduction of glycomacropeptide-based products, as well as enhancements in taste and the variety of available formulations. However, their micronutrient content has received limited attention. This work aims to analyse the micronutrient composition of all PS formulations available in Italy for paediatric PKU patients and compare their micronutrient contribution to the recommended dietary allowance (RDA) and assess variability among products and age groups. Materials and Methods: The content of 28 micronutrients was analysed in 63 PSs, grouped according to the age ranges defined by the RDA guidelines: 0 to 6 months, 6 to 12 months, 1 to 3 years, 3 to 8 years, 8 to 14 years.

The micronutrient content was standardised for 10 g of protein equivalent (PE). Results: Compared to the RDA, many micronutrients were found to be over-supplemented across all age groups, particularly in the 0 to 6 month group, where peak levels were observed for vitamin K, chromium, and manganese. The 1 to 3 age group showed the lowest levels of supplementation, with most micronutrients falling within the sub-supplementation range. The variability in supplementation among PSs was broad and showed the highest values in the latter age ranges, reaching maximum levels for biotin and copper.

Among different ages, the variability was higher in the first two age ranges, particularly for vitamin A. Choline is not supplemented in many PSs across different age ranges. Conclusions: Many micronutrients supplemented in the PSs exceed the RDA for all age groups, with high variability among different PSs and age groups. When prescribing a PS, the daily amount of synthetic proteins of the diet should be considered in order to evaluate the real daily intake of micronutrients in a PKU diet.

Publication and source details

Original title: A Cross-Sectional Study on Protein Substitutes for Paediatric Phenylketonuria Diet: Time to Pay Attention

Albina Tummolo; Rosa Carella; Donatella De Giovanni; Vito Di Tullio; Letizia Lorusso; Nicola Bartolomeo

Nutrients · 2025

* Correspondence: albina.tummolo@policlinico.ba.it
†

These authors contributed equally to this work.

© 2025 by the authors.2025https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).This research received no external funding.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T05:03:01.703408+00:00

DOI: 10.3390/nu17111767 · PMC12157769